DL-S-Methyl-cysteine

DL-S-Methyl-cysteine is a thioether-containing cysteine derivative with a free carboxylic acid and a primary amino group, featuring a stereogenic center at the α-carbon and a side-chain thioether formed by S-methyl substitution. The DL designation indicates a racemic mixture of the L- and D-configured amino acid forms, which can influence stereochemical outcomes in peptide coupling, enzymatic recognition, and chiral downstream transformations. The thioether and amino/carboxyl functionality provide a defined reactivity profile for derivatization, including conversion to protected amino acid derivatives and controlled functional group interconversions without requiring thiol handling. As an amino acid-based intermediate, DL-S-Methyl-cysteine can serve as a chiral precursor in synthetic planning, a building block for thioether-bearing peptide analogs, and a substrate-like motif for biochemical assay development where thioether stability is advantageous.

1. Peptide Synthesis

DL-S-Methyl-cysteine is applied in peptide building and coupling chemistry where the α-amino and α-carboxyl groups enable standard amide bond formation after appropriate protection and activation. The S-methyl thioether side chain provides a non-thiol sulfur functionality that can be incorporated into peptide sequences to probe thioether effects on conformation, stability, and protease resistance without the redox sensitivity of cysteine thiols. Racemic stereochemistry can be used to generate mixed stereochemical peptide analogs for library construction and structure-activity relationship studies, while downstream resolution or stereoselective conversion can be integrated when enantiopure targets are required. Protected amino acid derivative strategies, such as N-protection and carboxyl activation, support compatibility with peptide coupling workflows and facilitate the preparation of thioether-containing peptide fragments for subsequent elongation.

2. Amino Acid Derivatization

DL-S-Methyl-cysteine is utilized in amino acid derivatization workflows where the free amino and carboxyl groups support formation of esters, amides, and coupling-ready intermediates for fine chemical synthesis. The thioether side chain can participate in targeted functional group transformations, including conversion to sulfonium or sulfoxide/sulfone analogs under controlled oxidation conditions, enabling downstream medicinal chemistry and chemical biology probes. Racemic availability supports rapid access to stereochemical variants for screening, while resolution routes can be applied when a single configuration is required for stereochemically defined conjugates. Functionalized derivatives derived from DL-S-Methyl-cysteine can then be used as intermediates for thioether-to-sulfur-oxidation chemistry, side-chain labeling reagents, or scaffold modifications in applied synthesis programs.

3. Chemical Biology Labeling

DL-S-Methyl-cysteine is suitable for chemical biology and biomolecule labeling strategies that require a stable sulfur-containing amino acid motif with defined thioether character. The thioether side chain can be leveraged to introduce sulfur-based handles into peptides or small molecules used for cellular uptake studies, protein interaction mapping, or assay development where thiol oxidation artifacts are undesirable. The amino acid backbone enables conjugation through amide coupling or orthogonal protection/deprotection schemes to attach the sulfur-bearing fragment to carriers, linkers, or detection scaffolds. DL-S-Methyl-cysteine's racemic nature can support comparative studies across stereochemical variants when stereochemical discrimination is not the primary readout, while enantiopure analogs can be prepared for experiments requiring stereochemical control of binding or recognition.

4. Process Chemistry Intermediate

DL-S-Methyl-cysteine is employed as a process chemistry intermediate for manufacturing routes targeting sulfur-functionalized amino acid derivatives and peptide building blocks. The presence of both amino and carboxylic acid functionalities allows conversion into protected amino acid derivatives and activated intermediates under scalable synthesis conditions, supporting downstream production of thioether-bearing fine chemicals. The S-methyl thioether group can reduce handling complexity relative to thiol-containing cysteine derivatives, since oxidation to disulfides is not inherent to the starting material's side chain. Industrial synthesis planning can incorporate protection-group selection for N- and carboxyl functionalities to control chemoselectivity during coupling and to streamline purification of intermediates used in pharmaceutical intermediate preparation and specialty chemical production.

5. Peptidomimetics And SAR Studies

DL-S-Methyl-cysteine is applied in peptidomimetic construction and SAR studies where incorporation of a thioether-bearing side chain can modulate physicochemical properties such as polarity, conformational preference, and metabolic stability. The α-amino acid framework supports placement of the sulfur-bearing motif into constrained analogs, while racemic stereochemistry can be used to generate stereochemical diversity for early-stage SAR mapping. Side-chain functionalization from the thioether, including controlled oxidation to higher oxidation-state sulfur analogs, can expand the chemical space of peptidomimetic scaffolds used to interrogate structure-function relationships. Downstream formation of analog panels from DL-S-Methyl-cysteine-derived intermediates supports systematic optimization of peptide-like molecules and amino acid-based constructs in applied research and industrial screening workflows.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists